#D2RProjectSpotlight
🧬 This project, co-funded by Médicament Québec, RNA Technologies and Therapeutics Inc., AReNA, NovoArc GmbH, and the Victor Phillip Dahdaleh Institute, aims to advance next-generation mRNA vaccines.
🔗 Learn more: buff.ly/NlIVF16
@mcgill-research.bsky.social
🧬 This project, co-funded by Médicament Québec, RNA Technologies and Therapeutics Inc., AReNA, NovoArc GmbH, and the Victor Phillip Dahdaleh Institute, aims to advance next-generation mRNA vaccines.
🔗 Learn more: buff.ly/NlIVF16
@mcgill-research.bsky.social
July 18, 2025 at 1:31 PM
#D2RProjectSpotlight
🧬 This project, co-funded by Médicament Québec, RNA Technologies and Therapeutics Inc., AReNA, NovoArc GmbH, and the Victor Phillip Dahdaleh Institute, aims to advance next-generation mRNA vaccines.
🔗 Learn more: buff.ly/NlIVF16
@mcgill-research.bsky.social
🧬 This project, co-funded by Médicament Québec, RNA Technologies and Therapeutics Inc., AReNA, NovoArc GmbH, and the Victor Phillip Dahdaleh Institute, aims to advance next-generation mRNA vaccines.
🔗 Learn more: buff.ly/NlIVF16
@mcgill-research.bsky.social
🔊#D2RProjectSpotlight: Poly-NS saRNA dengue vaccine: A novel platform for T cell-driven protection against severe dengue
🧬 Led by Silvia Vidal, this project will adapt an RNA dengue vaccine antigen to a self-amplifying RNA platform
🔗 Learn more:https://buff.ly/b3KkAW5
🧬 Led by Silvia Vidal, this project will adapt an RNA dengue vaccine antigen to a self-amplifying RNA platform
🔗 Learn more:https://buff.ly/b3KkAW5
July 16, 2025 at 1:32 PM
🔊#D2RProjectSpotlight: Poly-NS saRNA dengue vaccine: A novel platform for T cell-driven protection against severe dengue
🧬 Led by Silvia Vidal, this project will adapt an RNA dengue vaccine antigen to a self-amplifying RNA platform
🔗 Learn more:https://buff.ly/b3KkAW5
🧬 Led by Silvia Vidal, this project will adapt an RNA dengue vaccine antigen to a self-amplifying RNA platform
🔗 Learn more:https://buff.ly/b3KkAW5
🔊#D2RProjectSpotlight: Machine learning models for the design of RNA therapeutics: Development of experimental data
🧬 In partnership with Deep Genomics, this project aims to speed up the discovery of RNA-based medicines using artificial intelligence.
🔗 Learn more:https://buff.ly/54i060S
🧬 In partnership with Deep Genomics, this project aims to speed up the discovery of RNA-based medicines using artificial intelligence.
🔗 Learn more:https://buff.ly/54i060S
July 11, 2025 at 2:05 PM
🔊#D2RProjectSpotlight: Machine learning models for the design of RNA therapeutics: Development of experimental data
🧬 In partnership with Deep Genomics, this project aims to speed up the discovery of RNA-based medicines using artificial intelligence.
🔗 Learn more:https://buff.ly/54i060S
🧬 In partnership with Deep Genomics, this project aims to speed up the discovery of RNA-based medicines using artificial intelligence.
🔗 Learn more:https://buff.ly/54i060S
🔊#D2RProjectSpotlight: Conversion of a gene therapy into an RNA therapy using a novel nanoparticle system
🧬Researchers at @mcgill.ca in collaboration with QurCan Therapeutics are developing new RNA-based treatment for a rare neurodegenerative disorder
🔗Learn more:https://buff.ly/0NczaMJ
🧬Researchers at @mcgill.ca in collaboration with QurCan Therapeutics are developing new RNA-based treatment for a rare neurodegenerative disorder
🔗Learn more:https://buff.ly/0NczaMJ
July 9, 2025 at 2:09 PM
🔊#D2RProjectSpotlight: Conversion of a gene therapy into an RNA therapy using a novel nanoparticle system
🧬Researchers at @mcgill.ca in collaboration with QurCan Therapeutics are developing new RNA-based treatment for a rare neurodegenerative disorder
🔗Learn more:https://buff.ly/0NczaMJ
🧬Researchers at @mcgill.ca in collaboration with QurCan Therapeutics are developing new RNA-based treatment for a rare neurodegenerative disorder
🔗Learn more:https://buff.ly/0NczaMJ
🔊#D2RProjectSpotlight: The Jerry Pelletier Initiative
🧬Led by Mark Lathrop & Morag Park @mcgill.ca, the initiative looks for biomarkers and therapies for rare cancers hoping to create RNA-based treatments
🔗Learn more: buff.ly/uiRHAnm
#CancerResearch #RNAResearch
@mcgillgci.bsky.social
🧬Led by Mark Lathrop & Morag Park @mcgill.ca, the initiative looks for biomarkers and therapies for rare cancers hoping to create RNA-based treatments
🔗Learn more: buff.ly/uiRHAnm
#CancerResearch #RNAResearch
@mcgillgci.bsky.social
June 12, 2025 at 1:41 PM
🔊#D2RProjectSpotlight: The Jerry Pelletier Initiative
🧬Led by Mark Lathrop & Morag Park @mcgill.ca, the initiative looks for biomarkers and therapies for rare cancers hoping to create RNA-based treatments
🔗Learn more: buff.ly/uiRHAnm
#CancerResearch #RNAResearch
@mcgillgci.bsky.social
🧬Led by Mark Lathrop & Morag Park @mcgill.ca, the initiative looks for biomarkers and therapies for rare cancers hoping to create RNA-based treatments
🔗Learn more: buff.ly/uiRHAnm
#CancerResearch #RNAResearch
@mcgillgci.bsky.social
🔊#D2RProjectSpotlight: New hope for POLR3-related leukodystrophy patients
🧬Led by Geneviève Bernard @rimuhc.bsky.social , this project develops RNA treatments for a rare, neurodegenerative disorder affecting children.
🔗Learn more: buff.ly/Xcsv5NP
#RareDisease #RNA
@mcgill-research.bsky.social
🧬Led by Geneviève Bernard @rimuhc.bsky.social , this project develops RNA treatments for a rare, neurodegenerative disorder affecting children.
🔗Learn more: buff.ly/Xcsv5NP
#RareDisease #RNA
@mcgill-research.bsky.social
June 9, 2025 at 1:15 PM
🔊#D2RProjectSpotlight: New hope for POLR3-related leukodystrophy patients
🧬Led by Geneviève Bernard @rimuhc.bsky.social , this project develops RNA treatments for a rare, neurodegenerative disorder affecting children.
🔗Learn more: buff.ly/Xcsv5NP
#RareDisease #RNA
@mcgill-research.bsky.social
🧬Led by Geneviève Bernard @rimuhc.bsky.social , this project develops RNA treatments for a rare, neurodegenerative disorder affecting children.
🔗Learn more: buff.ly/Xcsv5NP
#RareDisease #RNA
@mcgill-research.bsky.social
🔊#D2RProjectSpotlight: RNA therapy for Schinzel-Giedion Syndrome (SGS)
🧬Led by Carl Ernst at @mcgill.ca, this project aims to develop RNA therapy for SGS, a rare genetic disease affecting the brain & lungs
🔗Learn more: buff.ly/b4ugUp8
#RareDisease #RNATherapy
@mcgill-research.bsky.social
🧬Led by Carl Ernst at @mcgill.ca, this project aims to develop RNA therapy for SGS, a rare genetic disease affecting the brain & lungs
🔗Learn more: buff.ly/b4ugUp8
#RareDisease #RNATherapy
@mcgill-research.bsky.social
June 5, 2025 at 1:16 PM
🔊#D2RProjectSpotlight: RNA therapy for Schinzel-Giedion Syndrome (SGS)
🧬Led by Carl Ernst at @mcgill.ca, this project aims to develop RNA therapy for SGS, a rare genetic disease affecting the brain & lungs
🔗Learn more: buff.ly/b4ugUp8
#RareDisease #RNATherapy
@mcgill-research.bsky.social
🧬Led by Carl Ernst at @mcgill.ca, this project aims to develop RNA therapy for SGS, a rare genetic disease affecting the brain & lungs
🔗Learn more: buff.ly/b4ugUp8
#RareDisease #RNATherapy
@mcgill-research.bsky.social
#D2RProjectSpotlight: Identifying pathogen targets for next-gen Mpox vaccines
🧬 Led by Jörg H. Fritz @mcgill.ca , this study aims to discover new targets for Mpox vaccines with @dalhousieu.bsky.social & University of Vienna
🔗 Learn more: buff.ly/OVYIXiI
#RNA #VaccineDevelopment
🧬 Led by Jörg H. Fritz @mcgill.ca , this study aims to discover new targets for Mpox vaccines with @dalhousieu.bsky.social & University of Vienna
🔗 Learn more: buff.ly/OVYIXiI
#RNA #VaccineDevelopment
June 4, 2025 at 1:15 PM
#D2RProjectSpotlight: Identifying pathogen targets for next-gen Mpox vaccines
🧬 Led by Jörg H. Fritz @mcgill.ca , this study aims to discover new targets for Mpox vaccines with @dalhousieu.bsky.social & University of Vienna
🔗 Learn more: buff.ly/OVYIXiI
#RNA #VaccineDevelopment
🧬 Led by Jörg H. Fritz @mcgill.ca , this study aims to discover new targets for Mpox vaccines with @dalhousieu.bsky.social & University of Vienna
🔗 Learn more: buff.ly/OVYIXiI
#RNA #VaccineDevelopment
🔊 #D2RProjectSpotlight: Pre-clinical mouse models to study RNA vaccines for Poxvirus
🧬Led by Silvia Vidal at @mcgill.ca , this project uses mouse models to evaluate new RNA vaccine approaches for poxvirus infection
🔗 Learn more: buff.ly/TwTQFGG
#RNAResearch
@mcgillscience.bsky.social
🧬Led by Silvia Vidal at @mcgill.ca , this project uses mouse models to evaluate new RNA vaccine approaches for poxvirus infection
🔗 Learn more: buff.ly/TwTQFGG
#RNAResearch
@mcgillscience.bsky.social
May 28, 2025 at 1:15 PM
🔊 #D2RProjectSpotlight: Pre-clinical mouse models to study RNA vaccines for Poxvirus
🧬Led by Silvia Vidal at @mcgill.ca , this project uses mouse models to evaluate new RNA vaccine approaches for poxvirus infection
🔗 Learn more: buff.ly/TwTQFGG
#RNAResearch
@mcgillscience.bsky.social
🧬Led by Silvia Vidal at @mcgill.ca , this project uses mouse models to evaluate new RNA vaccine approaches for poxvirus infection
🔗 Learn more: buff.ly/TwTQFGG
#RNAResearch
@mcgillscience.bsky.social
🔊#D2RProjectSpotlight: Exploring innate pulmonary resistance to Poxvirus
🧬Led by Erwin Schurr at @rimuhc.bsky.social , this project looks at how pulmonary immune cells fight poxvirus, aiming to find new treatments
🔗Learn more: buff.ly/6x0db3G
#RNA #InfectiousDiseases
@mcgill-research.bsky.social
🧬Led by Erwin Schurr at @rimuhc.bsky.social , this project looks at how pulmonary immune cells fight poxvirus, aiming to find new treatments
🔗Learn more: buff.ly/6x0db3G
#RNA #InfectiousDiseases
@mcgill-research.bsky.social
May 26, 2025 at 1:15 PM
🔊#D2RProjectSpotlight: Exploring innate pulmonary resistance to Poxvirus
🧬Led by Erwin Schurr at @rimuhc.bsky.social , this project looks at how pulmonary immune cells fight poxvirus, aiming to find new treatments
🔗Learn more: buff.ly/6x0db3G
#RNA #InfectiousDiseases
@mcgill-research.bsky.social
🧬Led by Erwin Schurr at @rimuhc.bsky.social , this project looks at how pulmonary immune cells fight poxvirus, aiming to find new treatments
🔗Learn more: buff.ly/6x0db3G
#RNA #InfectiousDiseases
@mcgill-research.bsky.social
🔊#D2RProjectSpotlight: A novel self-amplifying mRNA platform for Mpox vaccines
🧬Led by Leo Liu at @mcgill.ca, this project aims to develop a bivalent Mpox vaccine using a self-amplifying mRNA platform.
🔗Learn more: buff.ly/xGnHQGO
#RNAResearch #VaccineDevelopment
🧬Led by Leo Liu at @mcgill.ca, this project aims to develop a bivalent Mpox vaccine using a self-amplifying mRNA platform.
🔗Learn more: buff.ly/xGnHQGO
#RNAResearch #VaccineDevelopment
May 22, 2025 at 1:15 PM
🔊#D2RProjectSpotlight: A novel self-amplifying mRNA platform for Mpox vaccines
🧬Led by Leo Liu at @mcgill.ca, this project aims to develop a bivalent Mpox vaccine using a self-amplifying mRNA platform.
🔗Learn more: buff.ly/xGnHQGO
#RNAResearch #VaccineDevelopment
🧬Led by Leo Liu at @mcgill.ca, this project aims to develop a bivalent Mpox vaccine using a self-amplifying mRNA platform.
🔗Learn more: buff.ly/xGnHQGO
#RNAResearch #VaccineDevelopment
🔊#D2RProjectSpotlight: Analyzing Mpox-specific antibody responses
🧬Led by Jorg H. Fritz at @mcgill.ca, this project asks if immune memory from smallpox vaccination can be boosted by Mpox vaccines.
🔗Learn more: buff.ly/3BUK1ZX
#RNAResearch
@mcgill-research.bsky.social
🧬Led by Jorg H. Fritz at @mcgill.ca, this project asks if immune memory from smallpox vaccination can be boosted by Mpox vaccines.
🔗Learn more: buff.ly/3BUK1ZX
#RNAResearch
@mcgill-research.bsky.social
May 19, 2025 at 1:15 PM
🔊#D2RProjectSpotlight: Analyzing Mpox-specific antibody responses
🧬Led by Jorg H. Fritz at @mcgill.ca, this project asks if immune memory from smallpox vaccination can be boosted by Mpox vaccines.
🔗Learn more: buff.ly/3BUK1ZX
#RNAResearch
@mcgill-research.bsky.social
🧬Led by Jorg H. Fritz at @mcgill.ca, this project asks if immune memory from smallpox vaccination can be boosted by Mpox vaccines.
🔗Learn more: buff.ly/3BUK1ZX
#RNAResearch
@mcgill-research.bsky.social
🔊 #D2RProjectSpotlight: McGill Centre for Translational Research in Cancer
Scientific Director: Gerald Batist
MCTRC addresses an unmet need, bridging the gap between academic research and clinical practice.
🔗 Learn more: buff.ly/4275XSl
Scientific Director: Gerald Batist
MCTRC addresses an unmet need, bridging the gap between academic research and clinical practice.
🔗 Learn more: buff.ly/4275XSl
February 26, 2025 at 5:50 PM
🔊 #D2RProjectSpotlight: McGill Centre for Translational Research in Cancer
Scientific Director: Gerald Batist
MCTRC addresses an unmet need, bridging the gap between academic research and clinical practice.
🔗 Learn more: buff.ly/4275XSl
Scientific Director: Gerald Batist
MCTRC addresses an unmet need, bridging the gap between academic research and clinical practice.
🔗 Learn more: buff.ly/4275XSl
🔊 #D2RProjectSpotlight: @genomicsandpolicy.bsky.social
Scientific Director: Yann Joly
The Centre of Genomics and Policy at @mcgill.ca is an interdisciplinary research hub focused on law, medicine, bioethics, governance, and public policy in genomics and health.
🔗 Learn more: buff.ly/3DOzM07
Scientific Director: Yann Joly
The Centre of Genomics and Policy at @mcgill.ca is an interdisciplinary research hub focused on law, medicine, bioethics, governance, and public policy in genomics and health.
🔗 Learn more: buff.ly/3DOzM07
February 24, 2025 at 8:26 PM
🔊 #D2RProjectSpotlight: @genomicsandpolicy.bsky.social
Scientific Director: Yann Joly
The Centre of Genomics and Policy at @mcgill.ca is an interdisciplinary research hub focused on law, medicine, bioethics, governance, and public policy in genomics and health.
🔗 Learn more: buff.ly/3DOzM07
Scientific Director: Yann Joly
The Centre of Genomics and Policy at @mcgill.ca is an interdisciplinary research hub focused on law, medicine, bioethics, governance, and public policy in genomics and health.
🔗 Learn more: buff.ly/3DOzM07
🔊 #D2RProjectSpotlight: The McGill Research Center on Complex Traits
Scientific Director: Jörg Fritz
The Center combines genetic/genomic approaches with immunological studies to uncover mechanisms of pathogenesis in infectious and inflammatory diseases.
🔗 https://buff.ly/4gCEv3r
Scientific Director: Jörg Fritz
The Center combines genetic/genomic approaches with immunological studies to uncover mechanisms of pathogenesis in infectious and inflammatory diseases.
🔗 https://buff.ly/4gCEv3r
February 6, 2025 at 2:00 PM
🔊 #D2RProjectSpotlight: The McGill Research Center on Complex Traits
Scientific Director: Jörg Fritz
The Center combines genetic/genomic approaches with immunological studies to uncover mechanisms of pathogenesis in infectious and inflammatory diseases.
🔗 https://buff.ly/4gCEv3r
Scientific Director: Jörg Fritz
The Center combines genetic/genomic approaches with immunological studies to uncover mechanisms of pathogenesis in infectious and inflammatory diseases.
🔗 https://buff.ly/4gCEv3r
🔊 #D2RProjectSpotlight: McGill Centre for Viral Diseases
Scientific Director: Chen Liang
The Centre seeks solutions to life-threatening viral diseases through advancing research, enhancing visionary education, and adopting cutting-edge technology.
🔗https://buff.ly/3DZrSRm
Scientific Director: Chen Liang
The Centre seeks solutions to life-threatening viral diseases through advancing research, enhancing visionary education, and adopting cutting-edge technology.
🔗https://buff.ly/3DZrSRm
February 5, 2025 at 12:42 PM
🔊 #D2RProjectSpotlight: McGill Centre for Viral Diseases
Scientific Director: Chen Liang
The Centre seeks solutions to life-threatening viral diseases through advancing research, enhancing visionary education, and adopting cutting-edge technology.
🔗https://buff.ly/3DZrSRm
Scientific Director: Chen Liang
The Centre seeks solutions to life-threatening viral diseases through advancing research, enhancing visionary education, and adopting cutting-edge technology.
🔗https://buff.ly/3DZrSRm
📣 #D2RProjectSpotlight: @mcgillgci.bsky.social
Scientific Director: Morag Park
Supported by D2R’s Centre & Institutes Support program, GCI is advancing precision medicine, immunotherapy, predictive biomarkers & early detection to support D2R’s mission.
🔗https://buff.ly/427LcWY
Scientific Director: Morag Park
Supported by D2R’s Centre & Institutes Support program, GCI is advancing precision medicine, immunotherapy, predictive biomarkers & early detection to support D2R’s mission.
🔗https://buff.ly/427LcWY
January 24, 2025 at 2:00 PM
📣 #D2RProjectSpotlight: @mcgillgci.bsky.social
Scientific Director: Morag Park
Supported by D2R’s Centre & Institutes Support program, GCI is advancing precision medicine, immunotherapy, predictive biomarkers & early detection to support D2R’s mission.
🔗https://buff.ly/427LcWY
Scientific Director: Morag Park
Supported by D2R’s Centre & Institutes Support program, GCI is advancing precision medicine, immunotherapy, predictive biomarkers & early detection to support D2R’s mission.
🔗https://buff.ly/427LcWY
🔊 #D2RProjectSpotlight: Internship program in biomanufacturing
Principal Investigator: Amine Kamen
Allows students to gain deeper knowledge and technological skills in bioprocessing and biomanufacturing in industry settings.
🔗 buff.ly/4j9B5qv
Principal Investigator: Amine Kamen
Allows students to gain deeper knowledge and technological skills in bioprocessing and biomanufacturing in industry settings.
🔗 buff.ly/4j9B5qv
January 23, 2025 at 5:38 PM
🔊 #D2RProjectSpotlight: Internship program in biomanufacturing
Principal Investigator: Amine Kamen
Allows students to gain deeper knowledge and technological skills in bioprocessing and biomanufacturing in industry settings.
🔗 buff.ly/4j9B5qv
Principal Investigator: Amine Kamen
Allows students to gain deeper knowledge and technological skills in bioprocessing and biomanufacturing in industry settings.
🔗 buff.ly/4j9B5qv
🔊 #D2RProjectSpotlight: This project, led by Jo Anne Stratton (@mcgill.ca) aims to optimize RNA therapies to reverse cytotoxicity in ALSP patients & provide a disease-modifying treatment.
🔗https://buff.ly/40bYGOC
@theneuro.bsky.social @ircm.bsky.social
@martinsauvageau.bsky.social
#RNA
🔗https://buff.ly/40bYGOC
@theneuro.bsky.social @ircm.bsky.social
@martinsauvageau.bsky.social
#RNA
January 20, 2025 at 2:07 PM
🔊 #D2RProjectSpotlight: This project, led by Jo Anne Stratton (@mcgill.ca) aims to optimize RNA therapies to reverse cytotoxicity in ALSP patients & provide a disease-modifying treatment.
🔗https://buff.ly/40bYGOC
@theneuro.bsky.social @ircm.bsky.social
@martinsauvageau.bsky.social
#RNA
🔗https://buff.ly/40bYGOC
@theneuro.bsky.social @ircm.bsky.social
@martinsauvageau.bsky.social
#RNA
🔊#D2RProjectSpotlight: An mRNA strategy to restore CTNS expression in Cystinosis
Principal Investigator: Paul Goodyer (@RIMUHC1)
Funded by D2R & @genomequebec.bsky.social, it will show that CTNS #mRNA in a new lipid nanoparticle formulation can prevent kidney damage.
🔗https://buff.ly/3BQlRWN
Principal Investigator: Paul Goodyer (@RIMUHC1)
Funded by D2R & @genomequebec.bsky.social, it will show that CTNS #mRNA in a new lipid nanoparticle formulation can prevent kidney damage.
🔗https://buff.ly/3BQlRWN
January 17, 2025 at 2:57 PM
🔊#D2RProjectSpotlight: An mRNA strategy to restore CTNS expression in Cystinosis
Principal Investigator: Paul Goodyer (@RIMUHC1)
Funded by D2R & @genomequebec.bsky.social, it will show that CTNS #mRNA in a new lipid nanoparticle formulation can prevent kidney damage.
🔗https://buff.ly/3BQlRWN
Principal Investigator: Paul Goodyer (@RIMUHC1)
Funded by D2R & @genomequebec.bsky.social, it will show that CTNS #mRNA in a new lipid nanoparticle formulation can prevent kidney damage.
🔗https://buff.ly/3BQlRWN
🔊 #D2RProjectSpotlight: Therapeutic development of the CRISPR-Cas12a gene editing system
Principal Investigator: Masad Damha (McGill University)
This project involves nucleic acid chemistry and biology aimed at enhancing the drug-like properties of RNA therapeutics.
🔗https://buff.ly/40tQ8D9
Principal Investigator: Masad Damha (McGill University)
This project involves nucleic acid chemistry and biology aimed at enhancing the drug-like properties of RNA therapeutics.
🔗https://buff.ly/40tQ8D9
January 14, 2025 at 10:31 AM
🔊 #D2RProjectSpotlight: Therapeutic development of the CRISPR-Cas12a gene editing system
Principal Investigator: Masad Damha (McGill University)
This project involves nucleic acid chemistry and biology aimed at enhancing the drug-like properties of RNA therapeutics.
🔗https://buff.ly/40tQ8D9
Principal Investigator: Masad Damha (McGill University)
This project involves nucleic acid chemistry and biology aimed at enhancing the drug-like properties of RNA therapeutics.
🔗https://buff.ly/40tQ8D9